BUDESONIDE ORODISPERSIBLE TABLETS ARE SUPERIOR TO MAINTAIN AND EVEN FURTHER IMPROVE QUALITY OF LIFE IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 48-WEEKS, DOUBLE-BLIND, PLACEBO-CONTROLLED PIVOTAL EOS-2 TRIAL



This item was part of the Oesophageal, Gastric and Duodenal Disorders II (Posters) session at UEG Week 2019